Hearing News Watch

WASHINGTON, D.C. — The Hearing Industries Association (HIA), the only association in America to represent hearing aid technology, has announced the election of Brandon Sawalich, President and CEO of Starkey, as the new Chair of the Board of Directors. The HIA Board of Directors unanimously elected Mr. Sawalich to serve in the position following the retirement of outgoing Chair Sandy

Ear Science Institute Australia will develop a WA-headquartered Australasian first biobank to advance genetic therapies for childhood and adult hearing loss. The Australasian Hearing Registry and Biobank (The Aussie Ear Bank) will be the first of its kind in Australia to store tissue related to genetic-associated hearing loss with the goal of advancing personalized care and new treatments. A Game-Changing

MILAN, ITALY – Amplifon (EXM; Bloomberg: AMP:IM; Reuters: AMPF.MI), a global leader in hearing solutions and services, has announced the acquisition of the entire capital of MagicSon srl and Sonar srl. These two companies, based in Turin, collectively own 27 hearing centers across the regions of Piedmont and Valle d’Aosta. With this transaction, Amplifon seizes the opportunity to integrate two

AURORA, ILLINOIS – Sonova has announced a leadership change in its Hearing Instruments (HI) Wholesale North America business, as Nicholai Dessypris assumed the role of President on January 1, 2025. He is succeeding Sandy Brandmeier, who retired at the end of 2024 after a distinguished six-year tenure with Sonova and over 20 years of healthcare leadership. Nicholai Dessypris brings more

LONDON, UNITED KINGDOM — A team of scientists from University College London (UCL) has identified a specific genetic cause of conductive hearing loss, the most common type of hearing loss in children with Down syndrome. The discovery, published in eLife, offers new insights into the biology of hearing loss in this population and paves the way for improved diagnostic tools,

VANCOUVER, B.C. – Ears to You, a leading mobile hearing care franchise in Canada, has announced its expansion into Vancouver, British Columbia. The new territories will be led by James Roche, Vice President of Franchising at Ears to You, who is transitioning into franchise ownership. This move marks a significant milestone for both Roche and the company as it continues

Hearing Health & Technology Matters (HHTM) is excited to announce the launch of the Hearing Therapeutics Summit, a premier virtual event taking place February 4–5, 2025. This highly-anticipated symposium will bring together experts, researchers, and industry leaders to share insights and explore the latest developments in hearing therapeutics. Attendees can look forward to an engaging program highlighting key advancements, emerging

In a significant policy shift, the Department of the Air Force (DAF) has updated its medical waiver guidelines for hearing loss, offering a pathway for more individuals with mild to moderate hearing impairments to serve. This change, part of a broader overhaul that also addresses asthma and food allergies, reflects evolving medical standards and advancements in hearing aid and assistive

MONTPELLIER, FRANCE — Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat, and prevent hearing loss disorders, today announced the completion of enrollment for the first cohort of its Audiogene Phase 1/2 gene therapy clinical trial. Successful Completion of First Cohort Enrollment Marks Key Milestone Recruitment of the first cohort,

For decades, Auditory Brainstem Response (ABR) testing has been a cornerstone in audiology, primarily used for assessing hearing thresholds in infants, difficult-to-test populations, and individuals with suspected auditory nerve or brainstem disorders. By measuring the brain’s electrical responses to sound stimuli, ABR offers an objective, non-invasive assessment of auditory pathway integrity. However, a recent study published in Communications Biology reveals